PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $637,745 | -23.2% | 20,787 | +0.2% | 0.00% | -50.0% |
| Q2 2023 | $830,932 | -2.3% | 20,737 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $850,073 | +5.6% | 20,830 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $805,327 | -24.2% | 20,858 | +4.4% | 0.00% | -33.3% |
| Q3 2022 | $1,063,000 | +28.2% | 19,980 | +40.6% | 0.00% | +50.0% |
| Q2 2022 | $829,000 | -52.1% | 14,215 | -62.5% | 0.00% | -91.3% |
| Q4 2017 | $1,730,000 | +12.3% | 37,895 | +73.9% | 0.02% | -53.1% |
| Q2 2015 | $1,541,000 | – | 21,788 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |